• No results found

Table 2:

N/A
N/A
Info
Downloaden
Protected

Academic year: 2021

Share "Table 2:"

Copied!
1
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Download het nu ( 1 pagina )

Hele tekst

(1)

Table 2: Patient characteristics of patients with axSpA at baseline and one year (n=161).

Baseline One year

BASDAI 4.0 (2.1) 3.1 (2.0)

CRP 7.5 (10.5) 4.7 (6.6)

ASDAS 2.5 (1.0) 2.0 (0.8)

ASDAS, n(%)

Inactive disease (<1.3) 17 (11) 37 (23)

Moderate disease activity (<1.2) 44 (27) 64 (40)

High disease activity (≤3.5) 78 (49) 50 (31)

Very high disease activity (>3.5) 22 (14) 10 (6)

SF-36

PCS 28.4 (14.3) 36.9 (13.1)

MCS 48.2 (13.8) 49.3 (12.0)

BASFI 2.3 (2.2) 1.6 (2.0)

Results are presented as mean (SD) unless otherwise indicated. BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; SD, standard deviation; CRP, C-reactive protein; ASDAS, Ankylosing Spondylitis Disease Activity Index; SF-36, 36-item short form; PCS, Physical Component Summary; MCS, Mental Component Summary; BASFI, Bath Ankylosing Spondylitis Functional Index.

Referenties

Download het nu ( PDF - 1 pagina - 400.37 KB )

GERELATEERDE DOCUMENTEN

In early axial spondyloarthritis increasing disease activity is associated with worsening of health-related quality of life over time Miranda van Lunteren

In early axSpA, we assessed and quantified the association between change in Ankylosing Spondylitis Disease Activity Score (ASDAS) and HRQoL over time.. Methods: Baseline and

Table 4:

PCS, Physical Component Summary; β, beta; CI, confidence interval; ASDAS, Ankylosing Spondylitis Disease Activity Score. a 79 patients of 129 working patients provided information

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry

• In this analysis of patients with axial spondyloarthri- tis in the US-based Corrona Psoriatic Arthritis/ Spondyloarthritis Registry, we observed no differ- ences between patients

Validation and reliability of translation of the ASAS Health Index in a Colombian Spanish-speaking population with spondyloarthritis

Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity

Associations Between Cardiorespiratory Fitness and Arterial Stiffness in Ankylosing Spondylitis: A Cross-sectional Study

Objective: To assess associations between cardiorespiratory fitness (CRF), measured as peak oxygen uptake (VO 2 peak) and cardiovascular disease (CVD) risk, measured by

Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

The Ankylosing Spondylitis Disease Activity Score (ASDAS) is a measure of axial spondyloarthritis (axSpA) disease activity with validated cut-offs endorsed by the Assessment

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis

ASAS HI= ASAS Health Index; ASDAS=Ankylosing Spondylitis Disease Activity Index; BASDAI= Bath Ankylosing Spondylitis Disease Activity Index; BASFI=Bath Ankylosing Spondylitis

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies

assessed efficacy endpoints included assessments of Spondyloarthritis international Society (aSaS)20/40, Bath ankylosing Spondylitis Disease activity index (BaSDai), BaSDai50, aS